Modification on bile acids resulted in the identification of FXR/GPBAR1 modulators.
All derivatives were evaluated on FXR and GPBAR1 transactivation.
Cholanoic acids are the first example of GPBAR1 antagonists.
Cholanoic acids are novel chemical probes in FXR mediated liver disorders.